MiniMed 740G Medtronic Diabetes for Healthcare Professionals User Guide

MiniMed 740G Medtronic Diabetes for Healthcare Professionals

Mit Smart Guard Technologie
The Mini Med 740G System is an advanced insulin pump system with SmartGuardTM technology designed to provide better glucose control for patients with diabetes.

MiniMedTM Mobile App
The Mini Med Mobile App allows for easy tracking of glucose levels. When the patient’s glucose levels are too high or too low, they will receive notifications on their smartphone.

Smart Guard Technology
The Smart Guard technology included in the MiniMedTM 740G system helps to prevent low glucose levels, giving patients more control over their condition. It can predict and prevent low glucose levels before patients even notice any symptoms.

CareLinkTM
The Mini Med 740G System is compatible with CareLinkTM, a software program that allows healthcare professionals to remotely monitor and analyze patient data for better diabetes management.

GuardianTM Sensor 3
The Mini Med 740G System comes with the GuardianTM Sensor 3, a glucose sensor that continuously monitors glucose levels and provides accurate readings for better insulin delivery.

Specifications

• Glucose range: 70 mg/dl to 250 mg/dl (3.9 mmol/l to 13.9 mmol/l)
• Insulin delivery interruption: SmartGuardTM technology automatically interrupts insulin delivery when low glucose levels are expected

Setting up the MiniMedTM 740G System
To set up the MiniMedTM 740G System, follow these steps:

1. Insert the GuardianTM Sensor 3 into the designated area on the body.
2. Connect the MiniMedTM pump to the sensor.
3. Enter personal settings, such as basal rates and glucose targets, into the pump.
4. Follow the on-screen instructions to prime the pump and perform a system check.

Using the MiniMedTM Mobile App
To use the MiniMedTM Mobile App, follow these steps:

1. Download and install the MiniMedTM Mobile App on your smartphone.
2. Pair your smartphone with the MiniMedTM pump using Bluetooth technology.
3. Open the app and log in using your credentials.
4. View and track your glucose levels, receive notifications and access additional features and settings through the app.

CareLinkTM Integration
To integrate the MiniMedTM 740G System with CareLinkTM, follow these steps:

1. Create a CareLinkTM account on the official website or through the mobile app.
2. Connect your MiniMedTM pump to your CareLinkTM account using the provided instructions.
3. Review and analyze your glucose data, insulin delivery, and other relevant information through the CareLinkTM platform.

MiniMed Mobile App

For easy tracking of the Glucose levels. If the values of your patients too high or are too low, they receive one notification on your Smartphone. Trustworthy people can the CareLink™ Connect app download so that they can always stay up to date. Accu-Chek® Guide link Blood glucose meter The precise test results of the blood glucose meter for quick sensor calibration are sent wirelessly to the pump.

CareLink

Enables more effective conversations with your patients thanks to tailored reports, whether personal or via telemedicine. Your patients’ data can now simply be uploaded via the smartphone app.

Guardian Sensor 3
The CGM sensor (sensor for continuous Glucose measurement) measures all glucose values for 5 minutes and sends it to the pump.

Can provide better protection
Hypoglycemia offers than CSII therapy:

• 1 73% fewer hypoglycemias
• 79% less time in the hypoglycemic range 
• 84% fewer severe hypoglycemias 
• less nocturnal hypoglycemia

MiniMed 740G System mit SmartGuard Technologie

With the MiniMed™ 740G system with SmartGuard™ technology, your patients can manage more than 80% of severe Prevent hypoglycemia events without causing a significant increase in hyperglycemia.1# It can help reduce the frequency of both high and low sensor glucose values ​​and monitor sensor glucose To stabilize the resumption of insulin delivery.2# Sensor-assisted insulin pump therapy with interrupt function When threshold values ​​are reached, nighttime hypoglycemia is also reduced.3 Most of the SmartGuard™ technology Predicted hypoglycemia events do not reach the preset lower limit.2# SmartGuard™ technology helps1, too low Values ​​to avoid your patients more to give control.

SmartGuard technology
Interrupts insulin delivery, as soon as they are too low Sensor glucose level (SG) is expected. Time window for SmartGuard™ technology Continue basal delivery after the sensor glucose value has recovered. SG values. SmartGuard technology can reduce the risk of hypoglycemia in children with type 1 diabetes significantly without increasing the HbA1c value.

REFERENCES

1. Choudhary P, et al. Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management Diabetes Technol Ther. 2016; 18(5):288-291. 2. Zhong A. et al. Effectiveness of Automated
2. Insulin Management Features of the Medtronic 640G Sensor-Augmented Insulin Pump. Diabetes Technol Ther. 2016; 18(10): 657-663. 3. Bergenstal RM, et al.
3. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
4. The New England Journal of Medicine 2013;369(3):224-232. 4. Bosi E, et al.
5. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycemia adults with type 1 diabetes (SMILE): an open-label randomized controlled trial.
6. Lancet Diabetes Endocrinol 2019;7: 462–72. 5. Biester T. et al. ‘‘Let the Algorithm Do the Work’’: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric
7. Type 1 Diabetes Patients. Diabetes Technol Ther. 2017; 19(3):173-182.

The MiniMed™ 740G and MiniMed™ 640G systems are based on the same algorithm.

To upload data to CareLink™, patients must use the MiniMed™ Mobile App with

the sync feature to CareLink™ enabled. DE-IPT-2200080 © Medtronic 2022. All rights reserved. Medtronic and the Medtronic logo are trademarks of Medtronic™. This material does not replace the instructions for use, which always take precedence. It should not and should not be considered an exclusive source of information to be used in conjunction with the user manual.

Detailed information about operating instructions, indications, contraindications, and warnings, Please refer to the user manual for precautions and possible complications. Contact your Medtronic representative for more information. ACCU-CHEK AND ACCU-CHEK GUIDE LINK are trademarks of Roche Diabetes Care.

Read User Manual Online (PDF format)

Download This Manual (PDF format)

Download this manual  >>